Feifeng (Chimmy) Tao

Chimmy’s recent experience includes advising:

• The underwriters on the initial public offering of Yuanbao, a leader in the insurtech industry, on the NASDAQ
• The underwriters on the US$440 million initial public offering on the NASDAQ and concurrent private placements for WeRide, a global leader and a first mover in the autonomous driving industry. This transaction was awarded Equity Capital Markets Deal of the Year by China Business Law Journal’s Deals of the Year Awards 2024
• The underwriters on the HK$333 million initial public offering of Baiwang, a Chinese enterprise digitalization solutions provider, on The Stock Exchange of Hong Kong
• The initial purchasers on the issuance of US$1.5 billion convertible senior notes due 2029 by Trip.com
• The underwriters on the HK$985 million initial public offering of RoboSense Technology, a global leader in the LiDAR and perception solutions market, on The Stock Exchange of Hong Kong. This transaction was awarded Equity Capital Markets Deal of the Year by China Business Law Journal’s Deals of the Year Awards 2024
• The underwriters on the US$40.63 million initial public offering of American depositary shares on the NASDAQ for QuantaSing, an online learning service provider in China
• The underwriters in the secondary listing and US$1.07 billion initial public offering of Trip.com, a leading one-stop travel platform globally, on The Stock Exchange of Hong Kong
• The underwriters on the follow-on offering of US$1.42 billion American depositary shares by Futu Holdings Limited, a financial technology platform in China, on the NASDAQ
• The underwriters on the US$140 million initial public offering of American depositary shares on the NASDAQ for Adagene Inc., a clinical stage biopharmaceutical company in China
• The underwriters on the US$2.5 billion follow-on offering of American depositary shares by XPeng Inc., a leading Chinese smart electric vehicle company
• The underwriters on the US$709 million initial public offering of American Depositary Shares on the New York Stock Exchange for Yatsen Holding Limited, the parent company of Chinese cosmetics brand Perfect Diary
• Nam Tai Property Inc. on the US$170 million private placement of its common shares with investors Kaisa Group Holdings Ltd. and a large-scale integrated financial group based in Hong Kong
• The underwriters on the US$1.7 billion initial public offering of American depository shares on the New York Stock Exchange of XPeng Inc., a leading smart electric vehicle company in China
• The underwriters on the offering of 9,500,000 American depositary shares by Futu Holdings Limited
• The underwriters on the US$130 million initial public offering of American Depositary Shares on the New York Stock Exchange of Phoenix Tree Holdings Limited (Danke, one of the largest co-living platforms in China) 
• The underwriters on the US$100 million initial public offering of American depositary shares on the NASDAQ of Futu Holdings, an online brokerage platform
• Wenzhou Kangning Hospital Co., Ltd., the largest private psychiatric healthcare group in China as measured by revenue in 2014, on its US$101 million initial public offering of H shares on The Stock Exchange of Hong Kong *
• Hydoo International Holding Limited on its US$216.4 million initial public offering on The Stock Exchange of Hong Kong *
• CITIC Securities Co. Ltd. on its US$1.81 billion initial public offering of H shares on The Stock Exchange of Hong Kong *
• CITIC Dameng Holdings Limited on its US$266 million initial public offering on The Stock Exchange of Hong Kong *
• CITIC Private Equity on its US$111 million placing and sale of shares of 3SBio Inc*
• Credit Suisse Securities (USA) LLC and Barclays Capital Inc., on the US$75 million follow-on ADS offering and US$35 million ordinary shares concurrent private placement, and up to US$100 million at-the-market ADS offering of JinkoSolar Holding Co., Ltd.*

*Matter handled prior to joining Latham